IJI-Iranian Journal of Immunology. 2015; 12 (4): 311-318
in English
| IMEMR
| ID: emr-181367
ABSTRACT
Background:
Lack of sufficient information on the mechanism of plasma exchange[PE] therapy in multiple sclerosis [MS], has limited this treatment to individual patientswith severe relapses who have been refractory to other treatments. This is while PE isused very successfully as a first-line standard treatment in many other neuro-immunedisorders. Recent data suggest that Treg/Th17 counterbalance may indicate theboundaries between promotion and regulation of inflammatory responses in MS andTreg/Th17 ratio may be useful as a marker for monitoring the efficiency of MStherapies
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Language:
English
Journal:
Iran. J. Immunol.
Year:
2015
Similar
MEDLINE
...
LILACS
LIS